CNTN1 triggered the activation of endogenous T cells in a substantial proportion for up to 56% of patients with astrocytic and/or oligodendroglial IDH1-mutant lower grade gliomas, but none in healthy donors. This evidence concerns the gene CNTN1 and glioma.